SSTR4 and Alzheimer disease: Our previous studies have shown the selective SSTR4 (somatostatin receptor type 4) agonist, NNC 26–9100 (NNC), enhanced learning and memory in mouse models of AD, increased activity of the Aβ degrading enzyme neprilysin, and decreased protein expression of Aβ-oligomers [7–9].